Administration of the commonly used drug for bipolar disorder lithium decreased cis phosphorylated tau levels and reduced subsequent neurodegeneration, suggesting a potential therapeutic option for bipolar disorder and AD [99]. The gene discussed is MAPT; the disease is Alzheimer disease.